Antihemophilic Factor (Recombinant) (Afstyla) and Tamoxifen
Determining the interaction of Antihemophilic Factor (Recombinant) (Afstyla) and Tamoxifen and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: antihemophilic factor
Brand name: Hemofil-M, Koate-DVI, Monoclate-P, Advate, Adynovate, Afstyla, Eloctate with Fc Fusion Protein, Helixate FS, Kogenate FS, Kovaltry, Novoeight, Nuwiq, Recombinate, Xyntha, Jivi, Obizur
Synonyms: Antihemophilic factor (human), Antihemophilic Factor (Human)
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Antihemophilic Factor (Recombinant) (Afstyla)-Tamoxifen Citrate
- Antihemophilic Factor (Recombinant) (Afstyla)-Tamoxifen Solution
- Antihemophilic Factor (Recombinant) (Afstyla)-Tamoxifen Tablets
- Antihemophilic Factor (Recombinant) (Afstyla)-Tamsulosin
- Antihemophilic Factor (Recombinant) (Afstyla)-Tamsulosin Capsules
- Antihemophilic Factor (Recombinant) (Afstyla)-Tamsulosin Hydrochloride
- Tamoxifen-Antihemophilic Factor (Recombinant) (Helixate FS and Kogenate FS)
- Tamoxifen-Antihemophilic Factor (Recombinant) (Kovaltry and Novoeight)
- Tamoxifen-Antihemophilic Factor (Recombinant) (Nuwiq)
- Tamoxifen-Antihemophilic Factor (Recombinant) (Recombinate)
- Tamoxifen-Antihemophilic Factor (Recombinant) (Xyntha)
- Tamoxifen-Antihemophilic factor (recombinant) pegylated-aucl Intravenous